- In December 2023, Moon Surgical revealed plans to expand its Maestro robot for soft tissue robotic surgery into the U.S. market. Supported by Nvidia's AI chip expertise and the venture capital arm of Johnson & Johnson, JJDC, this move aims to offer a competitive advantage over established companies such as Intuitive Surgical. The company intends to provide surgeons with advanced robot-assisted tools, simplifying complex soft tissue surgeries and enhancing precision in the operating room
- In January 2023, Zimmer Biomet completed the acquisition of Embody, Inc., a medical device company specializing in soft tissue healing. This strategic move aims to integrate Embody’s collagen-based biointegrative solutions, such as TAPESTRY RC for rotator cuff repair and TAPESTRY for tendon healing, into Zimmer Biomet's portfolio. By adding these innovative products, Zimmer Biomet enhances its market presence and strengthens its offerings in the orthopedic soft tissue repair sector
- In December 2022, Stryker launched the Citrefix disposable suture anchor system, crafted from the bioresorbable elastomeric material Citregen. This innovative system is designed to support grafted tissue healing during surgical procedures, utilizing its unique chemical and mechanical properties. The Citrefix anchor aids in tissue repair and promotes healthy bone growth, offering a more effective solution for orthopedic surgeries
- In May 2022, Paragon 28, Inc. introduced its innovative Suture Anchor System, "Grappler," designed to address challenges in ligament reconstruction during acute foot and ankle surgeries and soft tissue tensioning. The system features Grappler anchors made from both PEEK and titanium materials, with the PEEK anchors available in a convenient single kit that includes all necessary instruments for the repair process. These preloaded anchors, available in sizes 4.5 mm and 5.5 mm, come equipped with sutures and needles, offering a streamlined solution for effective soft tissue repair
- In January 2021, Smith & Nephew acquired Integra LifeSciences Holdings Corporation’s Extremity Orthopedics business for USD 240 million. This strategic acquisition aimed to strengthen Smith & Nephew's extremities segment, enhancing its offerings in shoulder replacement as well as foot and ankle treatments. The move is expected to drive growth in these key areas, expanding the company's presence in the orthopedic market
Frequently Asked Questions
The market is segmented based on Segmentation, By Therapeutic Site (Knee, Shoulder, Hip, and Others), Product Type (Fixation Devices, Tissue Patch, and Laparoscopic Instruments), Procedure (Anterior Cruciate Ligament, Rotator Cuff, Vaginal Prolapse, Lateral Epicondylitis, Achilles, Gluteal Tendon, Biceps Tenodesis, Hip Arthroscopy, Cruciate Ligaments Repair, and Pelvic Organ Prolapse), End User (Hospitals, Ambulatory Centers, and Orthopedic Clinics) – Industry Trends and Forecast to 2032
.
The Global Orthopedic Soft Tissue Repair Market size was valued at USD 31.88 USD Billion in 2024.
The Global Orthopedic Soft Tissue Repair Market is projected to grow at a CAGR of 6% during the forecast period of 2025 to 2032.
The major players operating in the market include LifeCell, Johnson & Johnson Services , Smith & Nephew Plc, BD, Wright Medical Group N.V., Medtronic, and more,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
